Gene modified D29 phage and application thereof in MTB detection
By genetically modifying the D29 phage, the fluorescence signal intensity and survival time are enhanced, and combined with photoacoustic computational tomography technology, the problems of weak fluorescence signal and short window period in MTB detection are solved, and fast and sensitive MTB detection is achieved.
Patent Information
- Application Number
- CN202410997990.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-24
- Publication Date
- 2024-11-08
AI Technical Summary
The existing MTB detection methods have problems such as long detection cycles, easy missed detection and inability to distinguish bacterial life and death. The fluorescence signal is weak and the detection window period is short, making it difficult to achieve fast and reliable deep tissue detection.
By genetically modifying the D29 phage, the promoter L5 and near-infrared fluorescent protein iRFP were introduced, and the endolysin genes LysA, lysB and Holin were knocked out, the fluorescent protein expression time and phage survival time were extended, the fluorescence signal intensity and detection window period were improved, and the light was combined. Acoustic computing tomography technology realizes MTB in situ detection.
It significantly shortens the MTB detection time, improves the detection sensitivity and speed, extends the fluorescence detection window period, simplifies the detection process, and is suitable for applications in areas with limited resources.
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of bacterial detection, and in particular to a genetically modified D29 bacteriophage and its application in MTB detection. Background Art
[0002] Tuberculosis is one of the most deadly infectious diseases caused by MTB. MTB can cause tuberculosis in multiple organs and multiple parts of the abdomen through hematogenous spread and lymphatic drainage. Conventional CT and other detection methods have difficulty in detecting this type of tuberculosis. The development of rapid and reliable MTB detection and identification methods is crucial for the prevention and treatment of organ tuberculosis.
[0003] At present, non-biological methods for detecting Mycobacterium tuberculosis have problems such as long cycle, easy to miss detection, and inability to distinguish between dead and alive bacteria. In recent years, bacteriophages with strong specificity, rapid reproduction, and high accuracy have been developed for biological detection of MTB, which is expected to improve the difficulties faced by traditional non-biological methods. The earliest artificial phage was the luciferase reporter phage (LRPs) constructed by Pearson et al. Although it can specifically infect MTB, it still has the problem that tuberculosis fluorescence and background fluorescence are difficult to distinguish and cannot be directly used for clinical sample detection. Based on LRP, Jain et al. replaced luciferase with fluorescent protein GFP. Compared with LRP, although GFP can emit fluorescence without any reaction substrate, it still has the problem that the fluorescent signal is easily absorbed and cannot be used for deep tissue detection. Near-infrared fluorescent protein (iRFP) can solve this problem of imaging in deep tissues. Filonov et al. used iRFP to clearly observe the internal organs of living organisms, while Shcherbakova et al. introduced iRFP670 into NCr mice and combined it with photoacoustic computed tomography (PACT) imaging technology to achieve multiple imaging of tumor tissues. The above studies have proved that iRFP has good tissue penetration, but there are still problems such as weak fluorescence reporter signals and short detection window periods caused by the rapid lysis of host cells by infecting phages. Therefore, improving the performance of existing phage detection and solving the problems of weak fluorescence reporter signals and short detection "window periods" in phage detection strategies for MTB infection is the key to whether phage detection strategies can be effectively implemented. Summary of the invention
[0004] The object of the present invention is to provide a genetically modified D29 phage, which can prolong the survival time of the phage, facilitate rapid infection of host cells, delay the degradation rate of the phage to MTB, and prolong the detection window period of the reporter fluorescent protein.
[0005] Another object of the present invention is to provide an application of genetically modified D29 phage in MTB detection, which can improve the sensitivity of MTB detection, can be used to infect the host at the infection site, can realize MTB in situ detection, shorten the detection time, and simplify the detection process.
[0006] The embodiments of the present invention are implemented by the following technical solutions:
[0007] A genetically modified D29 phage uses pNZ123 to construct a series of template plasmids for homologous recombination, and a series of phage recombination factors are obtained by homologous recombination-mediated nonsense mutation and gene introduction of the phage genome; wherein LysA has a nonsense mutation at the 25th amino acid, TGC mutates to TGA, lysB has a nonsense mutation at the 22nd amino acid, TGG mutates to TGA, Holin has a nonsense mutation at the 18th amino acid, TCG mutates to TAG, a 666bp long DNA fragment before the capsid protein is introduced into the promoter L5, and a 2000bp long DNA fragment after the capsid protein is introduced into P2A-iRFP.
[0008] An application of the genetically modified D29 phage as described above in MTB detection.
[0009] The technical solution of the embodiment of the present invention has at least the following advantages and beneficial effects:
[0010] In the present invention, the inventor intends to use synthetic biology methods to transform bacteriophages to increase their fluorescence intensity and extend the "window period" of fluorescence detection. According to literature review, mild phages cannot quickly infect bacteria, so they are not effective in infecting tuberculosis. Relatively speaking, the highly invasive D29 phage has been widely studied because it can specifically infect and lyse tuberculosis bacteria. Existing studies have shown that it has a strong ability to infect and lyse MTB, making it one of the most suitable phages for this project. Therefore, this study intends to use D29 phage as a chassis cell for synthetic biology transformation.
[0011] The basis for rapid detection of MTB is the high-intensity expression of fluorescent protein initiated by phage promoter. Promoter hsp60 is the earliest studied and most widely used promoter in tuberculosis bacteriophage. McNerney et al. successfully detected dormant tuberculosis bacteria through hsp60 promoter, but there are problems of insufficient expression of fluorescent protein and weak fluorescence signal. Therefore, it is necessary to explore a promoter with higher expression efficiency. Promoter PL (L5) is derived from the left arm of the gene structure of mycobacterial phage L5, which has the characteristics of promoting high-efficiency expression of protein, but phage L5 itself is a mild phage, and its infection ability and lysis ability are weak, which is difficult to be used for rapid detection of tuberculosis. Based on this, the inventors tried to introduce promoter PL (L5), PT7 and Phsp60 into D29 phage to express fluorescent protein iRFP in early experiments. It was found that the fluorescence intensity of PL (L5) group was about 8 times that of Phsp60 group and 6 times that of PT7 group. Therefore, the addition of promoter PL (L5) is expected to solve the problem of low efficiency of fluorescent protein expression in D29. However, sustained high expression of fluorescent protein is another key to extending the window period, that is, extending the expression time of iRFP fluorescent protein.
[0012] Bacteriophages ensure timely lysis of host cells through porin (Holin), peptidoglycan hydrolase (LysA) and mycoyl arabinogalactose esterase (LysB). Holin targets the plasma membrane and perforates the mycobacterial cell membrane, allowing the hydrolase to diffuse into the periplasm and cause cell lysis, while LysA and LysB hydrolyze the peptidoglycan layer and ensure cell lysis, of which LysA is responsible for decomposing the peptidoglycan in the peptidoglycan layer and LysB is responsible for decomposing the extracellular bacterial acid layer. Holin, LysA and LysB play a decisive role in the bacterial lysis process. When the three are inhibited or knocked out individually, the bacterial lysis can be delayed to a certain extent. By knocking out the three endolytic enzyme genes at the same time, it is expected to delay the lysis of cells to the greatest extent. Knocking out the endolytic enzyme genes Holin, LysA and LysB at the same time is also expected to prolong the expression time of eGFP fluorescent protein.
[0013] Phages are a special type of virus that can infect bacteria. They cannot infect tissue cells that are more complex than bacteria and are not pathogenic to humans. Safety tests on phages have been conducted on human volunteers, and it has been determined that the subjects did not have any adverse reactions. The administration method is oral or directly applied to wounds, eyes, ears or noses. It has been verified in practice that it is not only safe but also has significant efficacy. The above studies show that phages are safe and harmless to the human body. In the field of biological detection, artificially modified phages are used for rapid in vitro detection of pathogens such as Mycobacterium tuberculosis, Escherichia coli and Staphylococcus aureus. Therefore, the inventors directly apply artificial phages modified based on synthetic biology to the infection site, and realize near-infrared fluorescent protein in Mycobacterium tuberculosis cells through photoacoustic computed tomography (PACT).
[0014] Through molecular biological recombination methods, the promoter L5, near-infrared fluorescent protein iRFP and self-cleaving polypeptide P2A were introduced into the D29 phage genome to enhance the expression of iRFP, and the endolytic enzyme gene LysA was knocked out to slow down the degradation rate of TMB by phage D29, thereby extending the detection window of the reporter fluorescent protein. In addition, the ability of the phage to decompose lysozyme can be reduced, prolonging the survival time of the phage.
[0015] Genetically modified D29 phage is used to detect MTB. By inserting fluorescent or bioluminescent reporter genes into the phage, detectable signals can be quickly generated after bacterial infection, improving the sensitivity and speed of detection. In addition, the phage can also be used directly to infect host cells and can survive for a long time, thereby maintaining fluorescence for a long time, and conveniently realizing MTB in situ detection. This method can complete the detection within a few hours, significantly shortening the detection time compared to traditional methods. By improving the sample processing and signal detection steps, the operation process is simplified, which is suitable for promotion and application in areas with limited resources. DETAILED DESCRIPTION
[0016] The present invention is further described below in conjunction with specific embodiments, but the embodiments do not limit the present invention in any form. Unless otherwise specified, the raw materials and reagents used in the embodiments of the present invention are conventionally purchased raw materials and reagents.
[0017] A genetically modified D29 phage uses pNZ123 to construct a series of template plasmids for homologous recombination, and a series of phage recombination factors are obtained by homologous recombination-mediated nonsense mutation and gene introduction of the phage genome; wherein LysA has a nonsense mutation at the 25th amino acid, TGC mutates to TGA, lysB has a nonsense mutation at the 22nd amino acid, TGG mutates to TGA, Holin has a nonsense mutation at the 18th amino acid, TCG mutates to TAG, a 666bp long DNA fragment before the capsid protein is introduced into the promoter L5, and a 2000bp long DNA fragment after the capsid protein is introduced into P2A-iRFP.
[0018] Through molecular biological recombination methods, the promoter L5, near-infrared fluorescent protein iRFP and self-cleaving polypeptide P2A were introduced into the D29 phage genome to enhance the expression of iRFP, and the endolytic enzyme genes LysA, lysB and Holin were knocked out to slow down the degradation rate of TMB by phage D29, thereby extending the detection window of the reporter fluorescent protein. In addition, the ability of the phage to decompose lysozyme can be reduced, prolonging the survival time of the phage.
[0019] The genetic modification methods are as follows:
[0020] 1. PCR was performed in a 2720 thermal cycler in a 0.2 mL tube containing 1 U platinum Taq, 0.8 μL dNTP (25 mM each), 4 μL 2 mM MgCl2, 1 μL 25 pmol / L primer, 10 μL buffer (600 mM Tris-SO4, 180 mM (NH4)2SO4), 4 μL DMSO and PCR graded water to a total reaction volume of 100 μL. The PCR cycle parameters were set to 95°C for 2 minutes, followed by 30 seconds, 30 seconds and 1 minute at 95°C, 56°C and 68°C, and finally 10 minutes at 68°C. The PCR product was purified from agarose gel using the QIAquick gel extraction kit (Qiagen, Hilden, GE) according to the manufacturer's protocol.
[0021] 2. PCR was performed on a 2720 thermal cycler. The reaction mixture contained 1U PFU DNA polymerase, 0.8μL, 25nM dNTPs, 1μL, 25pmol / L primer, 10μL buffer (750mM Tris-HCl (pH9.0); 500mM KCl; 200mM (NH4)2SO4), 4μL DMSO, 10ng plasmid DNA and PCR graded water, and the total reaction volume was 100μL. The cycle was set to 1 cycle at 95℃ for 5min, 30 cycles (95℃, 1min, 56℃, 30s, 72℃, 1.5min), and the last cycle was 72℃, 10min; the PCR product was gel purified using the QIAquick gel extraction kit;
[0022] A second PCR was performed to add more 50 bp at each end of the cassette and obtain a final recombination substrate with 100 bp homology on both sides of the target sequence. The PCR assay was performed in a 2720 thermal cycler with primers D29-p1 and D29-p2 in a reaction containing 0.2 μL (1U) Platinum-Taq High Fidelity DNA Polysaccharidase, 0.8 μL dNTPs (25 mM each), 4 μL, 2 mM MgCl2, 1 μL primer (25 pmol / L), 10 μL buffer (600 mM Tris-SO4, 180 mM (NH4)2SO4)), 44 L DMSO, 10 ng of the first PCR product and PCR graded water in a total reaction volume of 100 μL. The cycling parameters were set at 95°C for 1 cycle for 2 min, 30 cycles (95°C for 1 min, 57°C for 30 s, 68°C for 1.5 min), and a final cycle at 68°C for 10 min. PCR products were gel purified using the QIAquick Gel Extraction Kit.
[0023] 3. Keep the solution on ice for 15 minutes, load it into a 2 cm cuvette, and immediately perform electroporation using a Gene Pulser Xcell electroporation system with a pulse of 2500 V, 25 μF, and 1000 Ω; store the electroporated cells in 7H9 containing 10% ADC and 1 mM CaCl2 at 37°C / 250 rpm / 1 hour, gently mix with 4 ml of molten 7H9 soft agar (10% ADC, 1 mM CaCl2, 0.75% agar), and then add 500 μL of Mycobacterium smegmatis mc 2 155 were inoculated on 7H10. After incubation at 37°C for 16 hours, each primary plaque was transferred to 100 μL of phage buffer (10 mM Tris-HCl, pH 7.5; 10 mM MgSO4; 68.5 mM NaCl; 1 mM CaCl2).
[0024] The culturing of bacteriophage D29 is completed by 7H9 / 7H10 double-layer agar medium, comprising the following steps:
[0025] S1. Take out 10 sterile EP tubes, put 90μl 7H9 liquid culture medium in each EP tube, add 10μl D29 preservation solution to the first EP tube, and make 10-fold gradient dilution with 7H9 liquid culture medium until the dilution reaches 10. 10 times, mix evenly and number them 1-10;
[0026] S2. Take out the M. smegmatis bacterial solution in the logarithmic phase, OD 600 The value is 0.7, add 10 μl of bacterial solution to each EP tube, gently invert to mix evenly, and place at room temperature for 15 minutes;
[0027] S3. Add 3 ml of 7H9 Agar semi-solid medium to the mixed bacterial solution, mix it upside down, and evenly spread the semi-solid medium evenly on the prepared 7H9 Agar semi-solid medium. Wait for 30 minutes at room temperature. After the semi-solid medium is completely solidified, turn the plate upside down and put it in a 37°C incubator for static culture for 3 days.
[0028] S4. After 3 days, when double-layer plaques appear, collect the double-layer plates with the dilution multiple that is just enough to completely lyse the M. smegmatis colonies, gently scrape off the upper layer of semi-solid culture medium on the double-layer plates with a sterile cell scraper, collect them in a 15 ml sterile centrifuge tube, gently break up the scraped semi-solid culture medium with a sterile cell scraper, and then centrifuge at 9500 rpm and 4°C for 15 min. Collect the supernatant, which is the phage liquid, and filter it with a 0.22 μm filter to obtain the phage filtrate.
[0029] Further, the phage DNA extraction method comprises the following steps:
[0030] S1. Add RNaseA and DNaseI to the phage filtrate, mix and incubate, then add pre-cooled phage precipitation solution, mix, cool, centrifuge, and obtain a precipitate;
[0031] S2, adding lysis buffer to the precipitate, resuspending the phage by blowing, then adding sodium dodecyl sulfate, mixing and incubating, cooling, adding impurity precipitation solution, mixing and centrifuging to obtain a supernatant;
[0032] S3, adding binding solution to the supernatant and mixing, adsorbing on the adsorption column, centrifuging, discarding the waste liquid, adding rinsing solution, centrifuging, and taking out the adsorption column;
[0033] S4. Place the adsorption column in elution buffer, centrifuge, and take the elution solution to obtain phage DNA.
[0034] Among them, RNaseA is endoribonuclease, DNaseI is deoxyribonuclease I, and SDS is sodium dodecyl sulfate. After adding RNaseA and DNaseI, the DNA and RNA of the bacteria themselves are degraded and damaged; add ice-precooled phage precipitation liquid, and in a low temperature environment, the phage particles gradually settle down due to their weak water-taking ability, and the supernatant is removed by centrifugation, and the precipitated is the phage particles.
[0035] The main components of phage particles are proteins and nucleic acids. The phage particles are made into a suspension using Tris-HCl buffer. Under the action of SDS, the structure of the phage particles is destroyed, the capsid protein is dissolved, and the internal genomic DNA is released. Chloroform is added to kill the remaining bacteria and promote the separation of lipid substances. Centrifugation is performed to precipitate bacterial cells and bacterial fragments, and the supernatant is taken.
[0036] Adding isopropanol to the supernatant can significantly reduce the solubility between nucleic acids and water, precipitate nucleic acids from water, and reduce the interaction between nucleic acids and proteins, preventing the formation of nucleic acid-protein complexes. Under the action of isopropanol, DNA is specifically adsorbed to the adsorption column, and impurities cannot be adsorbed. Impurities are removed by centrifugation. Rinsing with ethanol can further reduce impurities in DNA.
[0037] Placing the adsorption column in TE buffer can release the DNA in the adsorption column and centrifuge it to achieve the purpose of DNA separation and purification.
[0038] The above extraction method can speed up the extraction of phage DNA, and the extraction can be completed within 2 hours at the fastest; the extraction yield is high, the purity is high, and the concentration of extracted genomic DNA reaches more than 100ng / μL; the extraction product is not contaminated by the host bacterial genomic DNA, thereby eliminating the interference of the host genomic DNA.
[0039] Furthermore, the lysis buffer is Tris-HCl buffer, the impurity precipitation solution is chloroform, the binding solution is isopropanol, the rinsing solution is ethanol, and the elution buffer is TE buffer.
[0040] A genetically modified D29 phage is used in the detection of MTB. The genetically modified D29 phage is used to detect MTB. By inserting a fluorescent or bioluminescent reporter gene into the phage, a detectable signal can be quickly generated after bacterial infection, thereby improving the sensitivity and speed of detection. In addition, the phage can also be directly used to infect host cells and can survive for a long time, thereby maintaining fluorescence for a long time, and conveniently realizing in situ detection.
[0041] Furthermore, a MTB detection method comprises the following steps:
[0042] S1. The sputum sample is placed in physiological saline for mixing, centrifugation, washing, secondary centrifugation, resuspending and filtering to obtain an MTB detection sample; by pre-treating the sputum sample, impurities in the sample can be removed, the purity of MTB can be improved, so that the phage can infect and lyse MTB, thereby accelerating the detection speed of MTB;
[0043] S2. Add the genetically modified D29 phage to the MTB test sample and culture it at 35-40°C for 1-2 hours. Under this condition, the phage is helpful to infect and lyse MTB.
[0044] S3. Use a fluorescence microscope or a bioluminescence detector to detect the fluorescence signal or bioluminescence signal in the sample.
[0045] In step S1, the initial centrifugation speed is 3000-4000 rpm for 10-15 min, the secondary centrifugation speed is 3000-4000 rpm for 5-10 min, the sample is rinsed with physiological saline and filtered with a 0.22 μm filter membrane. Under these conditions, the removal effect of impurities in the sputum sample is optimal.
[0046] Example 1
[0047] A genetically modified D29 bacteriophage comprises the following steps:
[0048] Phage culture:
[0049] S1. Take out 10 sterile EP tubes, put 90μl 7H9 liquid culture medium in each EP tube, add 10μl D29 preservation solution to the first EP tube, and make 10-fold gradient dilution with 7H9 liquid culture medium until the dilution reaches 10. 10 times, mix evenly and number them 1-10;
[0050] S2. Take out the M. smegmatis bacterial solution in the logarithmic phase, OD 600 The value is 0.7, add 10 μl of bacterial solution to each EP tube, gently invert to mix evenly, and place at room temperature for 15 minutes;
[0051] S3. Add 3 ml of 7H9 Agar semi-solid medium to the mixed bacterial solution, mix it upside down, and evenly spread the semi-solid medium evenly on the prepared 7H9 Agar semi-solid medium. Wait for 30 minutes at room temperature. After the semi-solid medium is completely solidified, turn the plate upside down and put it in a 37°C incubator for static culture for 3 days.
[0052] S4. After 3 days, when double-layer plaques appear, collect the double-layer plates with the dilution multiple that is just enough to completely lyse the M. smegmatis colonies, gently scrape off the upper layer of semi-solid culture medium on the double-layer plates with a sterile cell scraper, collect them in a 15 ml sterile centrifuge tube, gently break up the scraped semi-solid culture medium with a sterile cell scraper, and then centrifuge at 9500 rpm and 4°C for 15 min. Collect the supernatant, which is the phage liquid, and filter it with a 0.22 μm filter to obtain the phage filtrate.
[0053] Phage DNA extraction:
[0054] S1. Take 10 mL of amplified phage filtrate, add 20 μL RNaseA and 20 μL DNaseI, mix thoroughly, incubate at 37°C for 30 min, add 2 mL of ice-cold phage precipitation solution, mix gently and thoroughly, cool on ice for 1 h, centrifuge at 10000G and 4°C for 10 min, discard the supernatant, dry for 1 min, and the precipitated phage will be a transparent or slightly white precipitate;
[0055] S2. Add 500 μL Tris-HCl buffer to the precipitate obtained in step S1, resuspend the phage by pipetting, add 100 μL 20% SDS, immediately and gently invert and mix 6 times, incubate at 70°C for 15 min, then cool on ice, add 100 μL chloroform, immediately and gently invert and mix 6 times, centrifuge at 12000G, 4°C for 10 min to obtain a supernatant;
[0056] S3. Pipette the supernatant into a new EP tube, add an equal amount of isopropanol, vortex gently to mix, add the suspension to the adsorption column, centrifuge at 12000G for 1min, discard the waste liquid, add 700μL ethanol, centrifuge at 12000G for 1min, discard the waste liquid, repeat this process, put the adsorption column back into the EP tube, centrifuge at 12000G for 2min, and discard all the ethanol;
[0057] S4. Take out the adsorption column in step S3, put it into a clean EP tube, add 100 μL of TE buffer preheated in a 50°C water bath, leave it at room temperature for 1 min, centrifuge it at 12000G for 1 min, take the eluate, and obtain the phage DNA.
[0058] The DNA quantity and purity were measured using a nucleic acid protein analyzer, and the typical OD260 / OD280 ratio was 1.9.
[0059] The genetic modification methods are as follows:
[0060] 1. PCR was performed in a 2720 thermal cycler in a 0.2 mL tube containing 1 U platinum Taq, 0.8 μL dNTP (25 mM each), 4 μL 2 mM MgCl2, 1 μL 25 pmol / L primer, 10 μL buffer (600 mM Tris-SO4, 180 mM (NH4)2SO4), 4 μL DMSO and PCR graded water to a total reaction volume of 100 μL. The PCR cycle parameters were set to 95°C for 2 minutes, followed by 30 seconds, 30 seconds and 1 minute at 95°C, 56°C and 68°C, and finally 10 minutes at 68°C. The PCR product was purified from agarose gel using the QIAquick gel extraction kit (Qiagen, Hilden, GE) according to the manufacturer's protocol.
[0061] 2. PCR was performed on a 2720 thermal cycler. The reaction mixture contained 1U PFU DNA polymerase, 0.8μL, 25nM dNTPs, 1μL, 25pmol / L primer, 10μL buffer (750mM Tris-HCl (pH9.0); 500mM KCl; 200mM (NH4)2SO4), 4μL DMSO, 10ng plasmid DNA and PCR graded water, and the total reaction volume was 100μL. The cycle was set to 1 cycle at 95℃ for 5min, 30 cycles (95℃, 1min, 56℃, 30s, 72℃, 1.5min), and the last cycle was 72℃, 10min; the PCR product was gel purified using the QIAquick gel extraction kit;
[0062] A second PCR was performed to add more 50 bp at each end of the cassette and obtain a final recombination substrate with 100 bp homology on both sides of the target sequence. The PCR assay was performed in a 2720 thermal cycler with primers D29-p1 and D29-p2 in a reaction containing 0.2 μL (1U) Platinum-Taq High Fidelity DNA Polysaccharidase, 0.8 μL dNTPs (25 mM each), 4 μL, 2 mM MgCl2, 1 μL primer (25 pmol / L), 10 μL buffer (600 mM Tris-SO4, 180 mM (NH4)2SO4)), 44 L DMSO, 10 ng of the first PCR product and PCR graded water in a total reaction volume of 100 μL. The cycling parameters were set at 95°C for 1 cycle for 2 min, 30 cycles (95°C for 1 min, 57°C for 30 s, 68°C for 1.5 min), and a final cycle at 68°C for 10 min. PCR products were gel purified using the QIAquick Gel Extraction Kit.
[0063] 3. Keep the solution on ice for 15 minutes, load it into a 2 cm cuvette, and immediately perform electroporation using a Gene Pulser Xcell electroporation system with a pulse of 2500 V, 25 μF, and 1000 Ω; store the electroporated cells in 7H9 containing 10% ADC and 1 mM CaCl2 at 37°C / 250 rpm / 1 hour, gently mix with 4 ml of molten 7H9 soft agar (10% ADC, 1 mM CaCl2, 0.75% agar), and then add 500 μL of Mycobacterium smegmatis mc 2 155 were inoculated on 7H10. After incubation at 37°C for 16 hours, each primary plaque was transferred to 100 μL of phage buffer (10 mM Tris-HCl, pH 7.5; 10 mM MgSO4; 68.5 mM NaCl; 1 mM CaCl2).
[0064] In the genetically recombinant D29 phage, LysA had a nonsense mutation at the 25th amino acid, TGC mutated to TGA, lysB had a nonsense mutation at the 22nd amino acid, TGG mutated to TGA, Holin had a nonsense mutation at the 18th amino acid, TCG mutated to TAG, a 666bp long DNA fragment before the capsid protein was introduced into the promoter L5, and a 2000bp long DNA fragment after the capsid protein was introduced into P2A-iRFP.
[0065] Example 2
[0066] A method for detecting MTB comprises the following steps:
[0067] S1. Place the sputum sample in normal saline, shake gently for 15 minutes to mix evenly, centrifuge at 3000 rpm for 10 minutes, rinse the lower sediment with normal saline, centrifuge at 3000 rpm for 5 minutes, filter the resuspended sediment with a 0.22 μm filter membrane, and the filtrate after filtration is the MTB test sample;
[0068] S2, adding the genetically modified D29 phage obtained in Example 1 to the MTB test sample, and culturing at 35° C. for 1 h;
[0069] S3. Use a fluorescence microscope or a bioluminescence detector to detect the fluorescence signal or bioluminescence signal in the sample.
[0070] Example 3
[0071] A method for detecting MTB comprises the following steps:
[0072] S1. Place the sputum sample in normal saline, shake gently for 18 minutes to mix evenly, centrifuge at 3500 rpm for 12 minutes, rinse the lower sediment with normal saline, centrifuge at 3500 rpm for 8 minutes, filter the resuspended sediment with a 0.22 μm filter membrane, and the filtrate after filtration is the MTB test sample;
[0073] S2, adding the genetically modified D29 phage obtained in Example 1 to the MTB test sample, and culturing at 37° C. for 1.5 h;
[0074] S3. Use a fluorescence microscope or a bioluminescence detector to detect the fluorescence signal or bioluminescence signal in the sample.
[0075] Example 4
[0076] A method for detecting MTB comprises the following steps:
[0077] S1. Place the sputum sample in normal saline, shake gently for 20 minutes to mix evenly, centrifuge at 4000 rpm for 15 minutes, rinse the lower sediment with normal saline, centrifuge at 4000 rpm for 10 minutes, filter the resuspended sediment with a 0.22 μm filter membrane, and the filtrate after filtration is the MTB test sample;
[0078] S2, adding the genetically modified D29 phage obtained in Example 1 to the MTB test sample, and culturing at 40° C. for 1-2 h;
[0079] S3. Use a fluorescence microscope or a bioluminescence detector to detect the fluorescence signal or bioluminescence signal in the sample.
[0080] Test results
[0081] The unmodified D29 phage was used to detect MTB in Example 4 as a control group. The fluorescence intensity of MTB was detected by fluorescence microscope and flow cytometer, and the fluorescence maintenance time and the presence of plaques were observed to judge the performance of the artificial phage.
[0082] Lysozyme was used to release the phages in MTB cells and added to sputum samples of tuberculosis patients for co-culture at 37°C for 6 hours, and the results were analyzed under a fluorescence microscope. At the same time, the modified phages were injected into the abdominal cavity (MTB infection site) of tuberculosis model mice. After 4-6 hours of culture, the fluorescence in the mice was monitored in vitro using PACT technology to evaluate the detection efficiency of the recombinant phages.
[0083] The test results are as follows:
[0084] Table 1 Test results
[0085] Group Example 2 Example 3 Example 4 Control group Detection time ( / h) 3 3 3 2.2 Titer (CFU / ml) <![CDATA[1×10 12 ]]> <![CDATA[1×10 12 ]]> <![CDATA[1×10 12 ]]> <![CDATA[1×10 11 ]]> Detection sensitivity (%) 94.8 95.4 95.3 88.6
[0086] According to the test results in Table 1, the detection time of the genetically modified D29 phage is shorter and the sensitivity is higher.
[0087] In summary, the present application provides a genetically modified D29 phage, which can prolong the survival time of the phage, facilitate rapid infection of host cells, slow down the degradation rate of the phage for MTB, and prolong the detection window period of the reporter fluorescent protein. The genetically modified D29 phage is used to detect MTB. By inserting a fluorescent or bioluminescent reporter gene into the phage, a detectable signal can be quickly generated after bacterial infection, thereby improving the sensitivity and speed of detection.
[0088] The above are only preferred embodiments of the present invention and are not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A genetically modified D29 bacteriophage, Features: pNZ123 was used to construct a series of template plasmids for homologous recombination. Nonsense mutations and gene introduction of the phage genome were mediated by homologous recombination to obtain a series of phage recombination factors. Among them, LysA had a nonsense mutation at the 25th amino acid, TGC mutated to TGA, lysB had a nonsense mutation at the 22nd amino acid, TGG mutated to TGA, Holin had a nonsense mutation at the 18th amino acid, TCG mutated to TAG, a 666bp long DNA fragment before the capsid protein was introduced into the promoter L5, and a 2000bp long DNA fragment after the capsid protein was introduced into P2A-iRFP.
2. The genetically modified D29 phage according to claim 1, Features: The method for extracting bacteriophage DNA comprises the following steps: S1. Add RNaseA and DNaseI to the phage filtrate, mix and incubate, then add pre-cooled phage precipitation solution, mix, cool, centrifuge, and obtain a precipitate; S2, adding lysis buffer to the precipitate, resuspending the phage by blowing, then adding sodium dodecyl sulfate, mixing and incubating, cooling, adding impurity precipitation solution, mixing and centrifuging to obtain a supernatant; S3, adding binding solution to the supernatant and mixing, adsorbing on the adsorption column, centrifuging, discarding the waste liquid, adding rinsing solution, centrifuging, and taking out the adsorption column; S4. Place the adsorption column in elution buffer, centrifuge, and take the elution solution to obtain phage DNA.
3. The genetically modified D29 phage according to claim 2, Features: The lysis buffer is Tris-HCl buffer, the impurity precipitation solution is chloroform, the binding solution is isopropanol, the rinsing solution is ethanol, and the elution buffer is TE buffer.
4. Use of the genetically modified D29 bacteriophage according to any one of claims 1 to 3 in MTB detection.
5. The use according to claim 4, Features: The MTB detection method comprises the following steps: S1. Place the sputum sample in physiological saline, mix, centrifuge, rinse, centrifuge again, resuspend and filter to obtain an MTB test sample; S2, adding the genetically modified D29 phage to the MTB test sample and culturing at 35-40°C for 1-2h; S3. Use a fluorescence microscope or a bioluminescence detector to detect the fluorescence signal or bioluminescence signal in the sample.
6. The use according to claim 5, Features: In step S1, the initial centrifugation speed is 3000-4000 rpm, and the time is 10-15 min; the secondary centrifugation speed is 3000-4000 rpm, and the time is 5-10 min.
7. The use according to claim 5, Features: In step S1, the solution is rinsed with physiological saline and filtered with a 0.22 μm filter membrane.
